Who is the CEO of TherapeuticsMD, Inc.?

Mr. Marlan D. Walker J.D. is a business executive who currently serves as the CEO of TherapeuticsMD, Inc..

What is the Revenue Growth of TherapeuticsMD, Inc.?

The Average Revenue growth for TherapeuticsMD, Inc. according to last quarter updates is 35.25%.

What is TherapeuticsMD, Inc. operating Margin?

TherapeuticsMD, Inc. operating margin is -310.01% which shows how much profit TXMD earns from each dollar of sales, after subtracting the direct costs tied to generating that revenue.

In which market sector does TherapeuticsMD, Inc. operate?

TherapeuticsMD, Inc. falls under the Healthcare sector which thrives across multiple industries. It stays competitive through its diverse product lineup, which spans computer hardware, tech gadgets, video streaming services, and cloud computing solutions.

What is TherapeuticsMD, Inc. revenue growth?

TherapeuticsMD, Inc. has Revenue Growth of 35.25% according to the last quarter update.

TherapeuticsMD, Inc.

TXMD•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$1.09

$0.01(0.93%)

TherapeuticsMD, Inc. (TXMD) Stock Overview

Explore TherapeuticsMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth

35.25%

↑ 35.25%

Profit Growth

$-0.18

↑ 78.78%

EPS Growth

$-0.18

↑ 65.45%

Operating Margin

-310.01%

↑ 44.15%

ROE

-7.72%

↑ 78.78%

Dividend Yield

0.00%

Analyst Recommendations data is not available for TXMDAnalyst Recommendations details for TXMD are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

CEO

Mr. Marlan D. Walker J.D.

Employees

Headquarters

951 Yamato Road, Boca Raton, FL

Founded

2007

Frequently Asked Questions

;